Moreover, GBE1 promotes glioma progression by enhancing aerobic glycolysis through the inhibition of fructose–bisphosphatase 1 (FBP1), which reveals GBE1 as a potential target for glioma therapy. This evidence concerns the gene FBP1 and central nervous system cancer.